CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Children’s Hospital Association Unveils Bold New Brand to Lead the Future of Children’s Health
More Than a New Look: CHA's New Brand Reflects Our Commitment to Children
When Millimeters Matter: Pharmacy Teams Power Pediatric Care
Children’s Hospital Association Unveils Bold New Brand to Lead the Future of Children’s Health
New mission and identity signal a renewed commitment to unify perspectives, inform decisions, and drive progress.
Nov. 04, 2025
More Than a New Look: CHA's New Brand Reflects Our Commitment to Children
CHA’s new identity will unify our voice, amplify our impact, and put children’s health at the center of the national conversation.
Nov. 04, 2025
When Millimeters Matter: Pharmacy Teams Power Pediatric Care
Pharmacy teams at children’s hospitals handle tens of millions of medication doses for our nation's kids.
Oct. 22, 2025
